I am Ewoud van Tricht, co-owner and CEO of Kantisto in the Netherlands. With over 18 years of experience in the (bio)pharmaceutical industry, I began my career at Solvay Pharmaceuticals (later Abbott) in 2006 after completing my vocational education in laboratory technology. Early on, I realized that a Bachelor's degree was essential to achieving my goal of becoming an analytical method developer. Determined to pursue this, I balanced full-time work with part-time studies, earning a Bachelor's, Master's, and PhD in Analytical Chemistry between 2006 and 2020, while working at Abbott Healthcare and Janssen Vaccines and Prevention.Throughout my career, I have held various roles, including Head of Analytical Development (AD) and Quality Control (QC), gaining extensive experience in analytical development, validation, method transfer, and dossier writing. I have worked with small molecules, antibodies, proteins, viruses, virus-like particles, and natural killer cells at companies such as Solvay Pharmaceuticals (Abbott), Janssen Vaccines and Prevention, and Sanofi Cell Therapy Amsterdam.In recent years, I have specialized in Analytical Quality by Design (AQbD), delivering courses and implementing AQbD strategies across various pharmaceutical organizations.I have a keen interest in personal development, managing, and coaching individuals and teams. I derive satisfaction from restructuring and shaping teams to optimize performance, improve collaboration, and foster growth. I am driven by efficiency and the enhancement of business processes, continuously striving to improve the status quo to drive innovation and progress. My professional approach integrates successful methodologies into both scientific and managerial realms, such as AQbD, Agile, Lean, and situational leadership, to achieve efficient and effective outcomes.